Compare CBAT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBAT | DRIO |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 82.2M |
| IPO Year | N/A | N/A |
| Metric | CBAT | DRIO |
|---|---|---|
| Price | $0.86 | $10.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | ★ 122.0K | 26.4K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $161,757,685.00 | $24,732,000.00 |
| Revenue This Year | $16.06 | N/A |
| Revenue Next Year | $70.59 | $20.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $0.57 | $5.94 |
| 52 Week High | $1.28 | $31.00 |
| Indicator | CBAT | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 36.66 |
| Support Level | $0.88 | $11.93 |
| Resistance Level | $0.93 | $12.88 |
| Average True Range (ATR) | 0.03 | 0.75 |
| MACD | -0.00 | -0.21 |
| Stochastic Oscillator | 4.43 | 4.83 |
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.